EUVIMEDEUVIMED entdecken
Crossref

Tobacco, heated tobacco products, e-cigarette, alcohol, cannabis and other psychotropic substances. Polysubstance use during the COVID-19 pandemic in Italy.

Cosimo Campagni, Giuseppe Gorini, Andrea Amerio, Sonia Cerrai, Silvano Gallus, Alessandra Lugo, Luisa Mastrobattista, Claudia Mortali, Anna Odone, Chiara Stival, Giulia Carreras, “LOST IN ITALY” and “LOST IN TOSCANA” Study Investigators und 1 weitere

Annali dell Istituto Superiore di Sanità · 19.12.2024 · 60 (4) · 294-302

DOI: 10.4415/ann_24_04_08 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annali dell Istituto Superiore di Sanità, erschienen am 19.12.2024. Verfasst von Cosimo Campagni und 12 weiteren Autor:innen. Beteiligte Einrichtung: Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Florence, Italy. Hauptthemen laut MEDLINE: COVID-19, Psychotropic Drugs, Alcohol Drinking, Substance-Related Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Psychoactive substance use is largely found to involve multiple substances. In recent years, the COVID-19 pandemic has changed psychoactive substance use patterns. Aim of this study is to investigate profiles of polysubstance and their pattern during and after the COVID-19 pandemic. METHODS: We collected information on alcohol consumption, use of tobacco, cannabis and other psychotropic substances, and nicotine-containing electronic devices (NCEDs; i.e., heated tobacco products and electronic cigarettes) on representative samples of the Italian adult population in five surveys from 2020 to 2023 (3,000≤n≤6,600). We used a Latent Class Analysis model to identify substance use profiles and their associated variables in each time period. RESULTS: We initially identified two profiles, "light users", characterized by a low use of tobacco and NCEDs (3%-20%) and a 40% at-risk alcohol consumption, and "polysubstance users", characterized by a large use of all psychoactive substances. After the 2020 COVID-19 lockdown, we also found the "dual users" profile, which show a large use of tobacco (90%) and NCEDs (50%), and also alcohol (50%). Being "dual users" and "polysubstance users" were associated with younger age and high economic status, with strengths of association less pronounced during lockdown but more marked immediately thereafter. Moreover, reporting anxiety or depressive symptoms as well as using psychotropic drugs were strongly associated with both profiles, especially in the last two years. CONCLUSIONS: Heterogeneity of polysubstance users and their socio-demographic characteristics need to be considered to design tailored prevention interventions, with special attention to the new "dual users" profile, which confirmed the increasing trend in NCED use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Psychotropic DrugsAlcohol DrinkingSubstance-Related DisordersElectronic Nicotine Delivery SystemsHumansItalyAdultMaleFemaleMiddle AgedYoung AdultAdolescentAgedTobacco ProductsPandemicsSARS-CoV-2Cannabis

Substanzen

Psychotropic Drugs

Autor:innen und Institutionen

  • Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Florence, Italy.
  • Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università degli Studi di Genova, Genoa, Italy.
  • Consiglio Nazionale delle Ricerche, Istituto di Fisiologia Clinica, Pisa, Italy.
  • Dipartimento di Ricerca Epidemiologia Medica, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Centro Nazionale Dipendenze e Doping, Istituto Superiore di Sanità, Rome, Italy.
  • Dipartimento di Salute Pubblica, Medicina Sperimentale e Forense, Università degli Studi di Pavia, Pavia, Italy *The members of the "LOST IN ITALY" and "LOST IN TOSCANA" Study Investigators are listed before the referen…

Zitieren

APA

Campagni, C., Gorini, G., Amerio, A., Cerrai, S., Gallus, S., Lugo, A., Mastrobattista, L., Mortali, C., Odone, A., Stival, C., Carreras, G., “LOST IN ITALY” and “LOST IN TOSCANA” Study Investigators, & members of the “LOST IN ITALY” and “LOST IN TOSCANA” Study Investigators (2024). Tobacco, heated tobacco products, e-cigarette, alcohol, cannabis and other psychotropic substances. Polysubstance use during the COVID-19 pandemic in Italy. Annali dell Istituto Superiore di Sanità, 60(4), 294-302. https://doi.org/10.4415/ann_24_04_08

Vancouver

Campagni C, Gorini G, Amerio A, Cerrai S, Gallus S, Lugo A, et al. Tobacco, heated tobacco products, e-cigarette, alcohol, cannabis and other psychotropic substances. Polysubstance use during the COVID-19 pandemic in Italy. Annali dell Istituto Superiore di Sanità. 2024;60(4):294-302. doi:10.4415/ann_24_04_08

BibTeX
@article{Campagni2024,
  author = {Campagni, Cosimo and Gorini, Giuseppe and Amerio, Andrea and Cerrai, Sonia and Gallus, Silvano and Lugo, Alessandra and Mastrobattista, Luisa and Mortali, Claudia and Odone, Anna and Stival, Chiara and Carreras, Giulia and “LOST IN ITALY” and “LOST IN TOSCANA” Study Investigators, “LOST IN ITALY” and “LOST IN TOSCANA” Study Investigators and members of the “LOST IN ITALY” and “LOST IN TOSCANA” Study Investigators, members of the “LOST IN ITALY” and “LOST IN TOSCANA” Study Investigators},
  title = {Tobacco, heated tobacco products, e-cigarette, alcohol, cannabis and other psychotropic substances. Polysubstance use during the COVID-19 pandemic in Italy},
  journal = {Annali dell Istituto Superiore di Sanità},
  year = {2024},
  volume = {60},
  number = {4},
  pages = {294--302},
  doi = {10.4415/ann_24_04_08}
}
Kostenlos starten →